Bare Financial Services’s First Tracks Biotherapeutics TRAX Stock Holding History

Bare Financial Services’s Portfolio TRAX Stock Details TRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41K	Buy	+70	New	+$1.31K	﹤0.01%	1248

Other funds holding TRAX

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco New York $245B AUM

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Bare Financial Services's TRAX Position: Q2 2026 in Review

Bare Financial Services opened a new position in First Tracks Biotherapeutics (TRAX) in Q2 2026: 70 shares worth $1.41K. The stake represents ﹤0.01% of the portfolio and ranks #1248 among its holdings.

150 funds tracked by Wall St. Rank hold TRAX as of Q2 2026.

Bare Financial Services held 70 shares of First Tracks Biotherapeutics worth $1.41K as of Q2 2026.
First Tracks Biotherapeutics was a new Bare Financial Services position in Q2 2026.
First Tracks Biotherapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1248 holding.
150 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.